|
|
|
FDA
News Releases
On Women's Health Issues |
|
|
|
|
|
|
|
|
|
Archive: 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996
2004
2003
- FDA's Office
of Women's Health Awards 5-Year Research Contracts (Nov.
5, 2003)
- FDA Approves
Estrasorb For Treatment of Menopausal Hot Flashes (October
10, 2003)
- Recall
of Nortrel 7/7/7 Oral Contraceptive (July 11, 2003)
- WHIMS
Study on Estrogen/Progestin (May 27, 2003)
- FDA Revises
Finding on Estrogen/Androgen Combination Products in the
Treatment of Hot Flashes (April 10, 2003)
- FDA Approves
Expanded Use of HPV Test (March 31, 2003)
- FDA Approves
Lower Dose of Prempro, a Combination Estrogen and Progestin
Drug for Postmenopausal Women (March 14, 2003)
- FDA Proposes
New Warning for Over-the-Counter Contraceptive Drugs Containing
Nonoxynol-9 (Jan. 16, 2003)
- FDA Approves
New Labels for Hormone Therapy for Postmenopausal Women (Jan.
8, 2003)
2002
- FDA Proposes
Advisory Label on Products Containing AHA (Dec.
4, 2002)
- FDA Approves
New Treatment for Parasitic Infections in Pediatric Patients (Dec.
2, 2002)
- FDA Approves
Non-Stimulant ADHD Drug (Nov. 26, 2002)
- FDA Approves
Teriparatide to Treat Osteoporosis (Nov. 26, 2002)
- FDA Clears
Device to Treat Fibroids (Nov. 26, 2002)
- New Lab
Test Screens Pregnant Women for Group B Strep (Nov.
18, 2002)
- FDA, Pharmacia
Update Bextra Label with New Warnings (Nov. 15,
2002)
- FDA Approves
New Female Sterilization Device (Nov. 6, 2002)
- FDA's Office
of Women's Health Announces 2002 Research Contracts (Oct.
1, 2002)
- FDA and FSIS
Issue Health Advisory About Listeria (Sept. 13,
2002)
- Gonorrhea
Test Kits Recalled By Abbott Laboratories (Aug.
30, 2002)
- FDA Approves
GlucoWatch for Children With Diabetes (Aug. 27,
2002)
- Update
on Advisory for Norplant Contraceptive Kits (July
26, 2002)
- FDA Approves
First Treatment for Women with Constipation-Predominant
Irritable Bowel Syndrome (July 24, 2002)
- FDA Approves
Restricted Marketing of Lotronex (June 7, 2002)
- FDA Clears
New Device for Radiation Treatment for Breast Cancer (May
6, 2002)
- Dietary Supplement
Firm Signs Consent Decree with FDA to Stop Selling Product
Containing Ephedrine Hydrochloride (April 15, 2002)
- FDA Warns
About Possible Enterobacter Sakazakii Infections
in Hospitalized Newborns Fed Powdered Infant Formulas (April
12, 2002)
- Kava-containing
Dietary Supplements Linked to Serious Liver Toxicity (March
26, 2002)
- FDA Issues
Nationwide/International Alert on Potentially Dangerous
OB/GYN Surgical Devices (March 14, 2002)
- FDA Announces
Foods Advisory Committee to Meet on Methyl Mercury in Seafood (March
1, 2002)
- Brenda
J. Holman Promoted to Rear Admiral (Jan. 4, 2002)
2001
- FDA Warns
Consumers Not to Use the Dietary Supplement Lipokinetix (Nov.
20, 2001)
- FDA Approves
First Hormonal Contraceptive Skin Patch
(Nov. 20, 2001)
- FDA Approves
New Anti-Adhesion Treatment for Gynecologic Surgery (Nov.
19, 2001)
- FDA Announces
Changes to the Risk Management Program to Prevent Birth
Defects Caused by Accutane (Oct. 31, 2001)
- FDA Approves
First Hormonal Vaginal Contraceptive Ring (Oct.
3, 2001)
- FDA Funds
Research on Prescription Medications Used by Pregnant Women (Sept.
28, 2001)
- FDA Approves
Xeloda in Combination with Taxotere for Advanced Breast
Cancer (Sept. 10, 2001)
- Linda Tollefson,
D.V.M., Promoted to Rear Admiral (Aug. 15,
2001)
- FDA Updates
Safety Information for Miconazole Vaginal Cream and Suppositories (March
5, 2001)
- FDA Announces
Advisory on Methyl Mercury in Fish (Jan. 12, 2001)
- FDA Approves
Femara as First-Line Therapy for Advanced Breast Cancer (Jan.
10, 2001)
- FDA/Bristol
Myers Squibb Issues Caution for HIV Combination Therapy
With Zerit and Videx in Pregnant Women (Jan. 5,
2001)
2000
- Glaxo Wellcome
Decides to Withdraw Lotronex From the Market (Nov.
28, 2000)
- FDA's Dr. Frances
Kelsey To Be Inducted into National Women's Hall of Fame (Oct.
6, 2000)
- Update of Advisory
for Several Lots of Norplant Contraceptive Kits (Sept.
13, 2000)
- FDA Creates Medication
Guide for Lotronex: Health Professional Labeling Revised
to Help Manage Risk (Aug. 24, 2000)
- FDA Approves
Fluoxetine to Treat Premenstrual Dysphoric Disorder (July
6, 2000)
- Two Firms Get
FDA Approval to Continue Marketing Saline-Filled Breast
Implants (May 10, 2000)
- FDA Clears
New Female Sexual Therapy Device (May 10, 2000)
- FDA Issues
Approvable Letter for Mifepristone (Feb. 18, 2000)
- FDA Approves
Irritable Bowel Syndrome Treatment for Women (Feb.
9, 2000)
- FDA Approves
First Digital Mammography System (Jan. 31, 2000)
1999
1998
1997
1996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|